Presentation TCT 2018

Sham Controlled Trials Should Be the New Gold Standard for Device Trials!

Presenter: Bernard J. Gersh

September 23, 2018

REGISTER for free or LOG IN to view this content

Sham Controlled Trials Should Be the New Gold Standard for Device Trials!

Coronary

Presentation

TCT 2018

Up Next

Presentation TCT 2018

Patient-Specific Computer Simulation of TAVR in Bicuspid Aortic Valve Morphology

Presenter: Cameron Dowling

September 23, 2018

More slides +

Presentation TCT 2018

Case #2 Introduction: A Patient With Chronic CAD At High Bleeding Risk Requiring PCI

Presenter: Steven R. Bailey

September 23, 2018

Presentation TCT 2018

Who Is the High Bleeding Risk Patient, and How Should DAPT Duration Be Weighed Against Ischemic Risk?

Presenter: Roxana Mehran

September 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.